SCHEMBL2962011

SCHEMBL2962011

Cc1cccc(C2C=Cc3ccc(C)c(Br)c32)c1C

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.34
HTR2A P28223 1/20 0.32
HTR2B P41595 1/20 0.32
PBRM1 Q86U86 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2972733 0.88 PBRM1 (0.32) HTR2CPBRM1
SCHEMBL2967580 0.85 HTR2C (0.34) HTR2CHTR2AHTR2B
SCHEMBL2957332 0.83 HTR2C (0.35) HTR2CHTR2AHTR2BPBRM1
SCHEMBL2960040 0.81 CYP2A6 (0.36)
SCHEMBL2975815 0.78 HTR2C (0.36) HTR2CHTR2AHTR2B
SCHEMBL2965964 0.78 HTR2C (0.33) HTR2CHTR2AHTR2B
SCHEMBL2967545 0.77 HTR2C (0.33) HTR2CHTR2AHTR2B
SCHEMBL2962881 0.76 HTR6 (0.31) HTR2A
SCHEMBL2974129 0.76 HTR2C (0.34) HTR2CHTR2AHTR2B
SCHEMBL2968522 0.76 HTR2C (0.34) HTR2CHTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 HTR2C 2725/4885HTR2A 2923/4885HTR2B 1802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.